NovaBridge Biosciences vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $177 M for NovaBridge Biosciences, 509 times as much (market caps of Jan 5, 2024 for NovaBridge Biosciences and Oct 30, 2026 for Moderna, Inc.). NovaBridge Biosciences's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Both made a net loss: $46 M for NovaBridge Biosciences and $2.8 B for Moderna, Inc.
- Moderna, Inc. employs more people: 4,700 against 228 at NovaBridge Biosciences.
Market value, the same start = 100
From Jan 2021: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | NovaBridge Biosciences NBP | Moderna, Inc. MRNA · #274 in the world |
|---|---|---|
| Profile | ||
| Country | 🇨🇳 China | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2010 |
| Size | ||
| Market cap | $177 M* | $90.1 B |
| Revenue | — | $1.9 B |
| Net income | $-46 M▲ best | $-2.8 B |
| Employees | 228 | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | -21.4%▲ best | -28.9% |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Jan 2024; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, NovaBridge Biosciences or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $177 M for NovaBridge Biosciences, 509 times as much (market caps of Jan 5, 2024 for NovaBridge Biosciences and Oct 30, 2026 for Moderna, Inc.). NovaBridge Biosciences's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, NovaBridge Biosciences or Moderna, Inc.?
Both made a net loss: $46 M for NovaBridge Biosciences and $2.8 B for Moderna, Inc.
Which has more employees, NovaBridge Biosciences or Moderna, Inc.?
Moderna, Inc. employs more people: 4,700 against 228 at NovaBridge Biosciences.
More about NovaBridge Biosciences
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.